Despite the advances in neonatal pulmonology in last decades, neonatologists still encounter an acute pulmonary disease mainly associated with respiratory distress syndrome (RDS) and mechanical ventilation in very low birth weight infants (VLBWI), known as pulmonary interstitial emphysema (PIE).
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1
As a form of air leak syndrome, PIE is defined as the presence of entrapped air "bubbles" along the bronchovascular bundles resulting from a dissection of the interstitial or perivascular lung tissue. According to the distribution pattern and the time of occurrence, PIE can be classified as local or diffuse and acute or persistent.
2 Pathophysiologically, the trapped gas progressively impairs pulmonary gas exchange by compressing functional lung tissue and reducing pulmonary blood flow.
3
Management of consecutive hypoxemia and respiratory acidosis in PIE is challenging and may be aggravated by the development of pneumomediastinum, pneumothorax, or pneumopericardium. 4 While older studies from the pre-surfactant era reported a high incidence of PIE (32%) in VLBWI with RDS exposed to mechanical ventilation within the first 5 days of life, more recent data suggest a lower incidence (4.6%). 5, 6 Early surfactant administration and the increased use of new ventilation modes may be attributable to this considerable reduction in PIE in the very preterm population. 7, 8 Although closely linked to mechanical ventilation, early emphysematic changes in VLBWI may occur even with the sole application of nasal continuous positive airway pressure (CPAP). 9 Due to the increased use of noninvasive ventilation strategies and noninvasive surfactant administration techniques, we would like to present an uncommon case of VLBW twins who subsequently developed PIE during noninvasive respiratory support. We further discuss the etiopathology, potential preventive strategies, and the respiratory management in established PIE.
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throughout the active stage of PIE. At DOL 7, twin A was transferred to the intermediate care unit on high-flow nasal cannula (flow 61/min, room air). According to the National Institutes of Health (NIH) definition, the infant did not meet the criteria for BPD at 36 weeks gestational age (as per national institute of health definition).
10 Additional examination findings were intraventricular hemorrhage (unilateral, right side, grade IV) and hyperbilirubinemia. Twin B. Apgar scores were 7 at 1 and 9 at 5 minutes of age. Birth weight was 900 g (10th-25th centile). The infant was stabilized in the delivery room with NIPPV (PIP 16 cm H 2 
Discussion
In our two patients, clinical and radiological appearance of early PIE in VLBW twins with RDS occurred during exclusive noninvasive respiratory support. RDS in preterm neonates is a known risk factor for PIE, especially when treated with mechanical ventilation and the use of very high PIPs.
11
However, several authors report on the spontaneous evolution of PIE in preterm neonates even in the absence of invasive ventilation, including a set of twin VLBWI.
9,12-14
Prior to the development of PIE, all these cases reported in the literature had clinical and radiological signs of RDS, but were never treated with surfactant. Thus, it is unclear if mechanical ventilation is the main driver in the etiology of PIE or whether early PIE is rather the consequence of missed or delayed surfactant administration. Understanding the etiopathogenesis of this pulmonary disease is crucial and may have important implications in the respiratory management of RDS and PIE in the preterm population. Anatomical and functional airway characteristics in the early course of RDS are different as compared with other pulmonary diseases and may predispose VLBW to the development of early PIE. Ackermann et al hypothesized that in the surfactant deficient and structural immature lung, the compliance of the terminal gas exchange structures (i.e., the saccular and alveolar level) is reduced, while the airway compliance remains normal.
15 This is supported by Reynolds et al who have shown that the terminal airways of deceased neonates treated with positive pressure ventilation for RDS were usually dilated, but the distal air saccules were not inflated.
16
In the poorly recruited but ventilated lung, histology showed marked dilatation lesions of the bronchiolar and alveolar duct areas with the evidence of PIE in the lymphatic tissue around the pulmonary arteries. These findings suggest that the location of injury is the terminal conductive airway rather than alveolar or saccular rupture. 16 Considering the above mentioned aspects, it seems conclusive that preventive and therapeutic strategies to improve lung compliance and reduce exposure to volutrauma, such as antenatal steroids, early surfactant administration, and the use of volume targeted ventilation modes in VLBW infants will eventually decrease the incidence of PIE. administration is increasingly used in VLBWI to avoid mechanical ventilation and has been used in both twins in our case report. 21 In a recently conducted large multicenter trial by Kribs et al, the use of noninvasive surfactant application significantly reduced the incidence of pneumothoraces in a high-risk study population. 22 Unfortunately, the authors did not specifically address on the incidence of PIE or the potential adverse event of unilateral surfactant administration, which might have occurred in twin A. We can only speculate that earlier treatment with surfactant might have prevented the development of PIE in our siblings. In fact, surfactant treatment during active PIE with severe respiratory failure, as applied in twin B, is not evidence based and, if anything, should be restricted to cases where other recommended treatment options (i.e., high-frequency ventilation modalities) are ineffective. With regard to the timing of surfactant therapy in both twins, one could argue that using the FiO 2 as a single surrogate parameter for RDS severity may not adequately reflect the disease state and that the decision to treat with surfactant should be based on physiologic parameters (FiO 2 ) and reliable clinical scoring systems for RDS (i.e., Silverman score), as applied in the study by Kribs et al 22, 23 Although the twin status and the uncommon clinical course in both siblings may also point toward an infectious/inflammatory cause for PIE development, we did not find any clinical, microbiological, or laboratory evidence for chorioamnionitis or neonatal sepsis. 24, 25 Verma et al found that in utero exposure to high doses of magnesium sulfate (cumulative dose > 10 g) is an independent risk factor for PIE in extremely low birth weight infants. 26 In our case, the mother did receive a lower cumulative dose of magnesium sulfate (i.e., 5 g). The administration of antenatal corticosteroids (ANCS) has been shown to reduce the risk of morbidity and mortality for preterm neonates. Meta-analyses have demonstrated a lower risk of death, respiratory morbidity, intracranial hemorrhage, and necrotizing enterocolitis. 27 The timing of ANCS relative to preterm birth appears to be crucial with the greatest benefit if delivery occurs > 24 hours and < 7 days. 28 Benefits regarding the severity of RDS may dissipate after an interval of > 7 days between ANCS administration and birth, particularly infants who received antenatal steroids > 14 days prior to delivery.
29
In our twin case report, there was a delay between ANCS administration and delivery of 14 days. Whether a second course or a single booster of ANCS is beneficial regarding the risk and severity of RDS remains controversial with conflicting results reported from the literature but no significant harm in early childhood either. 30, 31 Although the meta-analysis showed less need for mechanical ventilation in infants treated with ANCS, the incidence of any air leak syndromes was not significantly reduced.
27
Respiratory management of established PIE is challenging and may include noninvasive and/or invasive ventilation strategies. In our view, stable respiratory and hemodynamic conditions justified a conservative management approach (nasal CPAP and lateral decubitus positioning) in twin A, while twin B required distinct intensive care support due to the disease progression with tension pneumothorax and significant respiratory acidosis. Initially, the ventilation strategy in sibling B comprised of a reduction in mean airway pressure by dropping PEEP, PIP, shortening the Ti, and high RR (►Fig. 2C). In theory, this should allow the interstitial air to escape and further avoid gas trapping while maintaining adequate expansion of the distal airways. 32 However, clinical data regarding the potential benefits or harm of this approach are restricted to successful case series. [32] [33] [34] Progressive respiratory acidosis in twin B forced us to switch the baby to HFOV with a rate of 480/min. Measures of oxygenation and ventilation quickly improved thereafter (►Fig. 2D). HFOV has been proposed as a "lung protective" ventilation strategy in preterm neonates because it offers the benefit of adequate gas exchange using very low tidal volumes and lower mean airway pressures. 35 In a large prospective case series, Squires et al reported on 19 cases of VLBWI with PIE (14 bilateral, 5 unilateral, respectively) that were managed with HFOV using very low oscillatory frequency of 300 to 360/min for a minimum period of 24 hours. 36 After transition to HFOV, a rapid and sustained improvement in oxygenation and ventilation was noted, particularly in the bilateral PIE group. Outcomes reported in the study were promising with a survival rate of 71% in the bilateral and 100% in the unilateral group. However, 90% of the survivors in the bilateral and 80% in the unilateral group were diagnosed with bronchopulmonary dysplasia. In our case report in twin B, we did not go down as low as a HFOV frequency of 480/min by reason of satisfying physiological responses at this rate. High frequency jet ventilation (HFJV), another mode of high frequency ventilation, appears to be the most promising ventilation strategy in preterm neonates with PIE. HFJV typically applies very short jet pulses (Ti 0.02-0.03, rate of 400-450/min), superimposed on a low continuous distending pressure, resulting in a prolonged expiratory cycle which may most effectively interrupt the pathogenesis of PIE. 37 One randomized controlled multicenter trial in the early 90s compared HFJV versus rapid rate conventional ventilation in preterm infants with active PIE and found some benefits of HFJV regarding the resolution of PIE for >24 hours and radiographic improvement with no significant differences in the incidence of bronchopulmonary dysplasia or intraventricular hemorrhage. 38 Notably, when survival resulting from rescue by the alternate therapy was excluded, survival rates were significantly higher in the HFJV group (64.9% vs 47.1%). Nevertheless, lack of availability of the HFJ ventilator limits its use, particularly in the Europe. Further treatment options for PIE with very limited evidence and variable outcomes include selective main bronchial intubation for unilateral diseases and even more invasively, the creation of an artificial pneumothorax.
39,40
Treatment of unilateral PIE by the use of Swan-Ganz catheter in unilateral PIE has also been successfully used and reported in the literature. infants who have been treated with CPAP. The administration of antenatal steroids, invasive, and/or noninvasive surfactant treatment in the early course of RDS and the use of lung protective ventilation strategies (volume targeted ventilation) may decrease the incidence of PIE in high-risk neonates. Ventilation strategies during active PIE include noninvasive respiratory support in stable selected cases, while distinct clinical respiratory instability should be managed using either conventional ventilation with supraphysiological RRs and short Tis, HFOV with lower rates or HFJV, if available. Since CPAP/NIPPV and noninvasive surfactant administration is increasingly used in neonatal intensive care, clinical awareness for PIE should be paid to VLBW neonates with deteriorating respiratory conditions undergoing noninvasive respiratory support. We would further encourage investigators to specifically report on the incidence of PIE in future clinical trials dealing with neonatal pulmonary short-and long-term outcomes.
